Home Lilly Forecasts Sales, Profit Drop on Rival Generic Drugs
 

Keywords :   


Lilly Forecasts Sales, Profit Drop on Rival Generic Drugs

2014-01-08 12:07:12| Biotech - Topix.net

Eli Lilly & Co., the leading U.S. maker of diabetes products, forecast a drop in 2014 profit and reduced its sales outlook because of generic competition to the its Cymbalta antidepressant and Evista drug for osteoporosis.

Tags: sales drop profit drugs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11()PC-88015\"2D
23.11180&100m
23.11kenG
23.11ps3 CECH-4300C HDMI500
23.11 UNDERTALE PIANO SCORE
23.11MM6 BM11-SEC3 LC
23.11
23.11Blu-ray
More »